Clinical Trial Update: Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

View source ↗

Summary

Clinical trial update on safety and efficacy of rifabutin in non-HIV patients, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-tuberculous Mycobacterial Diseases
• Tuberculosis

Drugs mentioned

• RIFABUTIN (Rifabutin)

Snippet

Sponsor: Pfizer | Conditions: Tuberculosis, Non-tuberculous Mycobacterial Diseases (Including MAC Disease) | Status: COMPLETED | Results posted: 2019-03-07